El Salvador's General Medicine Law, which went into effect last week, will decrease the prices paid for some 6,200 drugs by at least 30%, and the most-prescribed medicines could see price rollbacks of as much as 60%. The new law will also create an independent entity to oversee drug imports, prescriptions and distribution, as well as the classification of prescription-only and over-the-counter medications. Some multinational drugmakers have threatened to exit the El Salvadoran market.

Related Summaries